One type of antibody, IgE, triggers allergic responses, and the overproduction of IgE causes an over-zealous allergic reaction. Lymphocytes are the cells that make IgE. Recent studies have shown that a messenger molecule, leukotriene B4 (LTB4), can stimulate lymphocytes to overproduce IgE. Furthermore, mice that lack the enzyme 5-lipoxygenase (5-LO), which synthesizes LTB4, make less IgE than do normal mice. These results indicate that high amounts of the messenger LTB4 might cause the overproduction of IgE and that inhibiting the enzyme 5-LO would decrease IgE levels. The long-term objectives of this project, then, are to identify the source of lymphocyte-regulating LTB4 in humans, to determine what causes abnormally high amounts of LTB4 to be made at that site, and to gauge the importance of LTB4 overproduction to diseases, including those involving IgE overproduction. Tonsils are an example of mucosa-associated lymphoid tissue (MALT), a site of lymphocyte development. Preliminary results indicate that the epithelium of tonsils contains 5-LO and makes LTB4. This places LTB4 production, in MALT epithelium, in a place where it can affect lymphocyte development and IgE production. Also, tonsils from some patients appear to have dramatically greater amounts of 5-LO, suggesting that they may synthesize much more LTB4 than normal. Finally, preliminary results indicate that the 5-LO enzyme expressed in tonsils is different from the known 5-LO.
The specific aims of this project are 1) to isolate and characterize the gene for the tonsil 5-LO enzyme, as well as its regulatory region, 2) to determine the properties of this novel 5-LO, with emphasis on how its action is regulated, and 3) evaluate its expression in MALT other than tonsils. These studies on this new 5-LO enzyme will provide the foundation for studies on the factors that cause the overproduction of LTB4 and IgE, and for studies on the impact of blocking 5-LO action on IgE generation and allergic responses. Notably, 5-LO inhibitors have been approved for use in humans to treat asthma. These studies will indicate whether 5-LO inhibitors may also be useful in reducing allergic responses.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21AI048141-02
Application #
6374621
Study Section
Special Emphasis Panel (ZAI1-NN-I (M1))
Program Officer
Ridge, John P
Project Start
2000-09-01
Project End
2003-08-31
Budget Start
2001-09-01
Budget End
2003-08-31
Support Year
2
Fiscal Year
2001
Total Cost
$226,500
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Brock, Thomas G; Lee, Young-Jik; Maydanski, Elana et al. (2005) Nuclear localization of leukotriene A4 hydrolase in type II alveolar epithelial cells in normal and fibrotic lung. Am J Physiol Lung Cell Mol Physiol 289:L224-32
Luo, Ming; Jones, Sandra M; Peters-Golden, Marc et al. (2003) Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity. Proc Natl Acad Sci U S A 100:12165-70
Luo, M; Lee, S; Brock, T G (2003) Leukotriene synthesis by epithelial cells. Histol Histopathol 18:587-95
Jones, Sandra M; Luo, Ming; Peters-Golden, Marc et al. (2003) Identification of two novel nuclear import sequences on the 5-lipoxygenase protein. J Biol Chem 278:10257-63
Jones, Sandra M; Luo, Ming; Healy, Annette M et al. (2002) Structural and functional criteria reveal a new nuclear import sequence on the 5-lipoxygenase protein. J Biol Chem 277:38550-6
Hemak, Jason; Gale, David; Brock, Thomas G (2002) Structural characterization of the catalytic domain of the human 5-lipoxygenase enzyme. J Mol Model 8:102-12
Brock, T G; Maydanski, E; McNish, R W et al. (2001) Co-localization of leukotriene a4 hydrolase with 5-lipoxygenase in nuclei of alveolar macrophages and rat basophilic leukemia cells but not neutrophils. J Biol Chem 276:35071-7